[
    [
        {
            "time": "2023-10-16",
            "orginal_text": "医药生物行业周报：疫苗加强针接种工作陆续开启 关注三季报业绩预期差投资机会",
            "features": {
                "keywords": [
                    "疫苗",
                    "加强针",
                    "三季报",
                    "业绩预期差",
                    "投资机会"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业周报：疫苗加强针接种工作陆续开启 关注三季报业绩预期差投资机会",
            "scores": {
                "News_content": "医药生物行业周报：疫苗加强针接种工作陆续开启 关注三季报业绩预期差投资机会",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-16",
            "orginal_text": "北向资金净卖出额创近2个月新高，贵州茅台遭大幅抛售逾14亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净卖出",
                    "贵州茅台",
                    "抛售"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "北向资金净卖出额创近2个月新高，贵州茅台遭大幅抛售逾14亿元",
            "scores": {
                "News_content": "北向资金净卖出额创近2个月新高，贵州茅台遭大幅抛售逾14亿元",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-16",
            "orginal_text": "医药生物行业周报：季度业绩波动该如何应对",
            "features": {
                "keywords": [
                    "医药生物",
                    "季度业绩",
                    "波动"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "医药生物行业周报：季度业绩波动该如何应对",
            "scores": {
                "News_content": "医药生物行业周报：季度业绩波动该如何应对",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-16",
            "orginal_text": "匆匆终止 百克生物新冠疫苗项目“画大饼”",
            "features": {
                "keywords": [
                    "百克生物",
                    "新冠疫苗",
                    "项目终止"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "匆匆终止 百克生物新冠疫苗项目“画大饼”",
            "scores": {
                "News_content": "匆匆终止 百克生物新冠疫苗项目“画大饼”",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-16",
            "orginal_text": "融资客青睐7股，万事利买入占比高达48.60%",
            "features": {
                "keywords": [
                    "融资客",
                    "万事利",
                    "买入占比"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "其他"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "融资客青睐7股，万事利买入占比高达48.60%",
            "scores": {
                "News_content": "融资客青睐7股，万事利买入占比高达48.60%",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-16",
            "orginal_text": "医药生物行业：创新药国谈价格前瞻分析",
            "features": {
                "keywords": [
                    "医药生物",
                    "创新药",
                    "国谈价格",
                    "前瞻分析"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业：创新药国谈价格前瞻分析",
            "scores": {
                "News_content": "医药生物行业：创新药国谈价格前瞻分析",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]